{"id":12551,"date":"2024-10-11T19:38:50","date_gmt":"2024-10-11T17:38:50","guid":{"rendered":"https:\/\/valintermed.com\/?p=12551"},"modified":"2024-10-11T19:38:50","modified_gmt":"2024-10-11T17:38:50","slug":"peripartalnaya-kardiomiopatiya","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/peripartum-cardiomyopathy\/","title":{"rendered":"Peripartum cardiomyopathy"},"content":{"rendered":"
<\/div>\n

Peripartum cardiomyopathy (PPM) is a form of cardiomyopathy that develops in the last months of pregnancy or during the first month after delivery. This disease is characterized by progressive heart failure and in some cases may be associated with arrhythmias. The mechanisms leading to the development of PPM are still not fully understood, but they are believed to include both genetic predisposition and the influence of unfavorable environmental factors, such as infection, stress, and immune-mediated processes. Clinical manifestations of PPM include shortness of breath, fatigue, edema, and decreased overall physical activity. It is important to note that peripartum cardiomyopathy can develop in women without previous cardiovascular diseases, which emphasizes the importance of early diagnosis and timely treatment.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n